Department of Chemistry, Duke University, Durham, NC, 27708-0346, USA.
Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Angew Chem Int Ed Engl. 2017 Oct 16;56(43):13498-13502. doi: 10.1002/anie.201707641. Epub 2017 Sep 18.
While a myriad non-coding RNAs are known to be essential in cellular processes and misregulated in diseases, the development of RNA-targeted small molecule probes has met with limited success. To elucidate the guiding principles for selective small molecule/RNA recognition, we analyzed cheminformatic and shape-based descriptors for 104 RNA-targeted ligands with demonstrated biological activity (RNA-targeted BIoactive ligaNd Database, R-BIND). We then compared R-BIND to both FDA-approved small molecule drugs and RNA ligands without reported bioactivity. Several striking trends emerged for bioactive RNA ligands, including: 1) Compliance to medicinal chemistry rules, 2) distinctive structural features, and 3) enrichment in rod-like shapes over others. This work provides unique insights that directly facilitate the selection and synthesis of RNA-targeted libraries with the goal of efficiently identifying selective small molecule ligands for therapeutically relevant RNAs.
虽然已知无数非编码 RNA 在细胞过程中是必不可少的,并且在疾病中失调,但 RNA 靶向小分子探针的开发进展有限。为了阐明选择性小分子/RNA 识别的指导原则,我们分析了具有已知生物学活性的 104 个 RNA 靶向配体的化学信息学和基于形状的描述符(RNA 靶向 BIoactive ligaNd 数据库,R-BIND)。然后,我们将 R-BIND 与既有的 FDA 批准小分子药物和没有报道生物活性的 RNA 配体进行了比较。对于有生物活性的 RNA 配体,出现了几个显著的趋势,包括:1)符合药物化学规则,2)独特的结构特征,3)棒状形状的富集。这项工作提供了独特的见解,直接促进了 RNA 靶向文库的选择和合成,目的是有效地鉴定出具有治疗相关性的 RNA 的选择性小分子配体。